Typically materials that are more than 5 years old will be archived
Displaying 81 - 100 of 1340 results

November 18, 2021 Council Minutes

https://www.niams.nih.gov/about/working-groups/advisory-council/council-minutes/november-18-2021-council-minutes

DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE NATIONAL ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES ADVISORY COUNCIL MINUTES OF THE 106th MEETING November 18th, 2021 1:00 P.m. to 2:30 p.m. November 18th, 2021 Council Webcast I. CALL TO ORDER The 106th meeting of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council (NAMSAC) was held on November 18, 2021, via videoconference. The meeting was chaired by Dr. Robert H. Carter, Deputy Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Attendance Council members present: Dr. Joan M. Bathon, Professor of Medicine and Chief of the Division

NIAMS Coalition 2021 Outreach & Education Meeting Creating Connections for Science

https://www.niams.nih.gov/about/meetings-events/coalition/niams-coalition-2021-outreach-education-meeting-creating

Welcome and Announcements The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) held its eighth biennial Coalition Outreach and Education Meeting: Creating Connections for Science on October 27, 2021, as a virtual event due to the ongoing COVID-19 pandemic. The NIAMS Coalition is an independent group of more than 90 professional and voluntary organizations interested in the mission and research areas of the NIAMS. Seventy-five representatives from 44 Coalition organizations logged on for the meeting. Coalition Overview NIAMS Coalition co-chairs Anna Hyde, M.A., vice president of advocacy for the Arthritis Foundation, and Eryn Marchiolo, M.P.H., vice president of

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)

https://www.niams.nih.gov/grants-funding/funding-opportunities-search/late-stage-translation-biomedical-and-behavioral

This funding opportunity ( PAR-23-032) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that translate technology and therapeutic innovations from academic and other non-profit research sectors to the marketplace to advance the development of diagnostic and prevention tools or treatments for musculoskeletal, rheumatic or skin